Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
65.93
+1.39 (2.15%)
Feb 2, 2026, 4:00 PM EST - Market closed
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $2.8 billion as of February 2, 2026. Its market cap has increased by 57.24% in one year.
Market Cap
2.80B
Enterprise Value
2.48B
1-Year Change
57.24%
Ranking
Category
Stock Price
$65.93
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $2.80B, an increase of 808.23%. That is a compound annual growth rate of 51.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.74B | -21.18% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Catalyst Pharmaceuticals | 2.99B |
| Edgewise Therapeutics | 2.98B |
| Dyne Therapeutics | 2.95B |
| Disc Medicine | 2.92B |
| Apellis Pharmaceuticals | 2.86B |
| Adaptive Biotechnologies | 2.82B |
| IDEAYA Biosciences | 2.82B |
| Travere Therapeutics | 2.78B |